+ All Categories
Home > Documents > Weekly Q&A –Oct 15, 2020 - Massachusetts General Hospital · Enrollment Updates (as of Oct 15,...

Weekly Q&A –Oct 15, 2020 - Massachusetts General Hospital · Enrollment Updates (as of Oct 15,...

Date post: 29-Jan-2021
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
10
HEALEY ALS Platform Trial Sabrina Paganoni, MD, PhD Ø 1 Weekly Q&A – Oct 15, 2020
Transcript
  • HEALEY ALS Platform TrialSabrina Paganoni, MD, PhD

    Ø1

    Weekly Q&A – Oct 15, 2020

  • • Brief review of the HEALEY ALS Platform Trial • Updates

    - Enrollment- Sites- Patient Navigator

    • How to stay in touch and find a site near you

    YOUR QUESTIONS2

    AGENDA

  • HEALEY ALS Platform Trial ØAccelerates ALS Therapy Development

  • Intervention

    Disease Therapy A Therapy B Therapy C

    Platform

    Intervention

    Disease Therapy A

    Traditional

    Ø4

  • Perpetual adaptive trial-Open Label Extension offered

    Screening Regimen Assignment Regimen B

    Regimen A

    Regimen C

    (n=160 foreach regimen)

    3:1 Randomization

    within each Regimen

    (n=120 for active drug;n=40 for placebo)

    Verdiperstat

    CNM-Au8

    Placebo

    Placebo

    Screening 24 weeks on study drug (active:placebo = 3:1)

    Open Label Extension

    Placebo

    Open Label Extension

    Open Label Extension

    Ø Treatments were selected by ALS scientists and experts based on a competitive processØ The platform opened with the first 3 treatments – enrollment started in July 2020Ø The next treatment will be added soon (pridopidine by Prilenia)Ø We are in discussion with 3 companies for 2021!

    Zilucoplan

    5

  • 6

    Enrollment Updates (as of Oct 15, 2020)

    • 127 individuals with ALS signed informed consent• 74 are currently on study drug

    We will continue to update the ALS community on enrollment (website, webinars)

  • 7

    List of Enrolling Sites as of Oct 15, 2020More will be added soon

    Texas NeurologyMGHUTHSCSAHospital for Special CareHoly Cross HospitalThomas JeffersonHouston MethodistHenry Ford Health SystemBarrow Neurological InstituteOhio State University Northwestern UniversityUniversity of Chicago

    University of Nebraska Medical CenterLoma Linda University of WashingtonUniversity of IowaWashington UniversityUniversity of PennsylvaniaUniversity of MichiganForbes Norris MDA/ALS Research Center, CPMCPenn State HersheyUMassUniversity of MiamiUniversity of ColoradoWake Forest

  • 8

    Patient Navigator

    Phone: 833-425-8257 (HALT ALS)E-mail:[email protected]

    Catherine SmallAllison Pogemiller

    mailto:[email protected]

  • 9

    How to Find a Center Near You

    Contact Info of Participating Sites by State

    25 sites are actively enrollingMore will be added soon!

    Øhttps://www.massgeneral.org/neurology/als/research/platform-trial-sites

  • 10

    How to Receive Platform Trial Updates

    Sign up for the ALS Link Newsletter (for info on this trial and other research opportunities)

    https://www.massgeneral.org/neurology/als/services/clinical-trials-enrollment-coordination

    https://www.massgeneral.org/neurology/als/services/clinical-trials-enrollment-coordination

Recommended